Defunct Company
Total Trials
22
As Lead Sponsor
19
As Collaborator
3
Total Enrollment
1,364
NCT00004017
Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 29, 2000
Completion: Not specified
NCT00129337
Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies
Phase: Phase 1
Start: Jun 30, 2005
Completion: Aug 31, 2009
NCT00128271
Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection
Start: Aug 31, 2005
NCT00343525
Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C
Start: May 31, 2006
NCT00509301
Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
Start: Nov 30, 2006
Completion: Mar 31, 2010
NCT00503347
Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
Start: Jul 31, 2007
Completion: Jun 30, 2011
NCT00677716
Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
Completion: Nov 30, 2011
NCT00669591
A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
Start: Jan 31, 2008
Completion: Aug 31, 2010
NCT00687817
Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer
Start: Jun 30, 2008
Completion: Jul 31, 2010
NCT00669565
Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer
Start: Jul 31, 2008
NCT01138163
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Start: Jun 30, 2010
Completion: May 31, 2013
NCT01160601
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
Completion: Sep 30, 2013
NCT01272791
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Start: Jan 31, 2011
Completion: Mar 31, 2013
NCT01273948
Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection
Phase: Phase 1/2
Completion: Feb 29, 2012
NCT01323062
Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects
Role: Collaborator
Start: May 31, 2011
Completion: Oct 1, 2018
NCT01335204
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer
Start: Jun 30, 2011
NCT01632696
Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors
Phase: Early Phase 1
Start: Jun 30, 2012
Completion: May 31, 2016
NCT01999673
Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer
Phase: Phase 3
Start: Dec 31, 2013
Completion: Mar 31, 2017
NCT02651610
Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
Phase: Phase 2/3
Start: Dec 31, 2015
Completion: Jun 30, 2018
NCT02673814
Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
Start: Feb 29, 2016
Completion: Apr 30, 2018
NCT02685306
A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer
Start: Mar 31, 2016
Completion: Sep 30, 2017
NCT03139916
Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
Start: Sep 13, 2017
Completion: Aug 31, 2022